BACKGROUND: Roughness, sagging, and skin rash are common in patients with breast cancer treated with LH-RH analog plus tamoxifen or aromatase inhibitors as adjuvant postsurgical endocrine therapy. The use of topical retinol (vitamin A) has shown to be an efficacious cosmetic treatment.
OBJECTIVE: Peeling with an advanced retinol peel formulation based on 3% retinol, 4% triethyl citrate, 0.1% aminophil, bisabolol, and 1% vitamin E acetate, in a vehicle in an alcoholic solution has been successfully used to ameliorate skin appearance on subjects with photodamage and in the aged population. We aimed to verify its use during adjuvant chemotherapy.
METHODS: Four subjects experiencing skin issues during postsurgical adjuvant therapy for their breast cancer received retinol peel at least 6 weeks after stopping their postsurgery therapy as a low invasive aesthetic medical treatment to be used both at the dermatology desk and at home.
RESULTS: Retinol peel was effective, safe, and well-tolerated, improving skin brightness and firmness in all the patients, since 4 weeks after the beginning of the treatment. Patients declared to be satisfied with the treatment and their skin appearance letting them feel better for cancer recovery, too.
CONCLUSIONS: These preliminary observations suggest that the use of an advanced retinol peel formulation might improve skin appearance in women experiencing skin damages caused by adjuvant therapy after breast cancer surgery.

BACKGROUND: Although cosmetic products such as sunscreens and moisturizers are generally considered safe, they can be less effective or harmful if used improperly. Thus, pharmacist\'s awareness about cosmeceuticals is pivotal in counseling about the ingredients and the proper use of such products.
OBJECTIVE: To evaluate the awareness level of community pharmacists regarding cosmetic products particularly sunscreens and moisturizers in Jeddah, Saudi Arabia.
METHODS: This is a cross-sectional study conducted on 310 community pharmacists in Jeddah, Saudi Arabia, in the duration (June-November 2019).
RESULTS: With respect to the level of awareness toward sunscreen products, 74% of the participants demonstrated a clear understanding of Sun Protection Factor (SPF). In terms of sunscreen counseling and the impact of these products on drug-induced photosensitivity, the average awareness of participants was 62% and 55%, respectively. However, only 16% of participants were aware of the expiry date. The average pharmacist\'s knowledge of the expiration date of the moisturizers and the proper use/ingredients was 86% and 58%, respectively, while only 42% of participants responded correctly to the instructions for application of moisturizers. Cross-tabulation between the level of education and the need to acquire knowledge about cosmetics has shown that the majority of pharmacists has indicated that they need more knowledge about cosmetics.
CONCLUSIONS: Around 53% of community pharmacists are aware about the sunscreen part, while 62% have the knowledge about moisturizers. Hence, more cosmetic courses and workshops are recommended to raise level of awareness.

Numerous skin lesions have been commonly observed in individuals with diabetes mellitus. The common skin manifestations of diabetes mellitus are erythrasma, xanthomatosis, xanthelasma, phycomycetes and cutaneous infections like furuncolosis, candidiasis, carbuncle, dermatophytosis, etc. Diabetic dermopathy is the most common skin lesion found in patients with diabetes. It is typically seen in men aged above 50 years. In low-level laser therapy (LLLT), the entire lower limb was illuminated with the frequency of 20 Hz and wavelength of 830 nm for 9 min, and the treatment was divided into four parts. With the continued sessions of LLLT, the skin manifestations and neuropathy conditions improved drastically. On the 21st day, the skin colour was found to be normal. Also, there were significant changes in clinical findings for diabetic peripheral neuropathy. LLLT with specific exercises can promote healing of skin manifestations in individuals with type 2 diabetes mellitus. It can be used as an effective treatment modality for treating diabetic dermopathy.